Ressources

Nirmatrelvir/Ritonavir (Paxlovid): What Prescribers and Pharmacists Need to Know

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Dernière mise à jour: février 23, 2022

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Dernière mise à jour: février 23, 2022

The Impact of The COVID‑19 Pandemic on Chronic Disease Risk Factors

Product: — Evidence Synthesis Network

Disease Mechanism Epidemiology Infectious Diseases & Clinical Care

esnetwork.ca Dernière mise à jour: février 6, 2022

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Dernière mise à jour: janvier 21, 2022

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Dernière mise à jour: janvier 18, 2022

Fluvoxamine: What Prescribers and Pharmacists Need to Know

Product: — Science Table

Drug Interventions Healthcare Workers Practice Guidelines Treatments

covid19-sciencetable.ca Dernière mise à jour: janvier 12, 2022

Effectiveness, Use and Re-Use of Masks in Hospitals During the Omicron Wave

Product: — Evidence Synthesis Network

Community Prevention & Transmission Face Protection PPE Public Health & Implementation Transmission

esnetwork.ca Dernière mise à jour: janvier 10, 2022

Baricitinib for Hospitalized Patients with COVID-19

Product: — Science Table

Drug Interventions Hospital Care Treatments

covid19-sciencetable.ca Dernière mise à jour: janvier 8, 2022

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Dernière mise à jour: janvier 8, 2022

Protecting Vulnerable Patients From the COVID‑19 Variant Omicron in Hospital

Product: — Evidence Synthesis Network

Hospital Infection Control Transmission Vulnerable Groups Vulnerable Sub-populations

esnetwork.ca Dernière mise à jour: janvier 6, 2022